STAT+: Pharmalittle: We’re reading about an FDA rejection, 340B court battles, and more

<iframe
  src="https://statesidedaily.com/embed/cluster/b26110a2ea9ff6e94a89c07fdd5a0c17e13e880a"
  width="100%" height="320"
  style="border:0;max-width:680px"
  loading="lazy"
  title="STAT+: Pharmalittle: We&#8217;re reading about an FDA rejection, 340B court battles, and more"></iframe>